Cell Marque Lysozyme Rabbit Polyclonal Antibody - HSA Registration DE0510182
Access comprehensive regulatory information for Cell Marque Lysozyme Rabbit Polyclonal Antibody in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0510182 and owned by Cell Marque Corporation. The device was registered on December 26, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Lysozyme Rabbit Polyclonal Primary Antibody is intended for laboratory use in the detection of lysozyme in formalin-fixed, paraffin-embedded tissue stained on VENTANA BenchMark IHC/ISH instruments. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.